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George Palade's pioneering work in the 1960s had es- 
tablished the secretory pathway and its connection to 
the biogenesis of organelles as a major theme in eukary- 
otic cell biology (Palade, 1975). His disciples, including 
David Sabatini and Gunter Blobel, extended Palade's 
morphological approaches to the next level of analysis, 
involving subcellular fractionation and biochemical re- 
constitution to understand the mechanism of secretory 
polypeptide synthesis and vectorial translocation (Red- 
man and Sabatini, 1966; Dobberstein and Blobel, 1975). 
However, as of the end of the 1970s, little progress 
had been made in identifying proteins required foi" the 
organization and execution of the secretory pathway. 
Beisson and colleagues developed a genetic ap- 
proach to the discovery of proteins required for secre- 
tion to investigate mucocyst discharge in Paramecium 
(Beisson et al., 1976). Unfortunately, rudimentary and 
cumbersome genetic and molecular cloning techniques 
limited the utility of this system. However, Saccharo- 
myces cerevisiae was known to secrete glycoproteins 
(Van Rijn et al., 1972), and some intracellular organelles 
characteristic of a mammalian style secretory system 
had been visualized (Linnemans et al., 1977). Thus, a 
genetic approach in yeast, analogous to that used to 
dissect the cell division cycle (Hartwell, 1974), seemed 
appropriate to begin to investigate molecular aspects 
of the secretory pathway. 
We assumed that a clever genetic selection procedure 
would be necessary to identify rare, secretion-selective 
mutations. Unfortunately, neither of us knew much ge- 
netics, but our initial effort suggested that such mutants 
would not be so rare. In 1979, we published our first 
report on the isolation of a pleiotropic secretion mutant 
sec l  (Novick and Schekman, 1979). sec l  mutant cells 
accumulated secretory proteins and vesicles at the ex- 
pense of cell wall and plasma membrane expansion. 
However, the procedure used in the isolation of this 
mutant, from a relatively small collection of temperature- 
sensitive growth mutants, was not exactly as we had 
described in that paper. The seemingly clever idea was 
to select against cells expressing an inducible plasma 
membrane permease, the SO42- permease, which was 
known to actively concentrate chromate, a toxic mimic 
of sulfate. Mutagenized cells were incubated at a restric- 
tive temperature, induced for sulfate permease, and 
then incubated ovemight in the presence of chromate 
in an effort to kill cells competent in the cell surface 
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expression of the permease, sec l  emerged from this 
selection, but the procedure was abandoned when we 
found, in a reconstruction experiment, that sec I mutant 
cells were actually killed more efficiently than wild-type 
cells during the prolonged incubation at 37°C in medium 
containing chromate. Apparently, the secretory block 
imposed at the restrictive temperature is enough to kill 
a sec mutant cell even though it does not take up 
chromate. 
Given that sec l  was isolated despite the "antiselec- 
tion" procedure, we figured that a random screen would 
be preferable, so a set of ~100 ts isolates was surveyed 
for the accumulation of an enlarged intracellular pool of 
two secretory enzymes, invertase and acid phospha- 
tase. This resulted in one more sec mutant, but the 
procedure was tedious, so we resumed the hunt for an 
effective selection procedure. 
A couple of years earlier, Susan Henry, at Albert Ein- 
stein Medical School, had documented a tight coupling 
between net cell surface growth and inositol metabo- 
lism, suggesting that plasma membrane enlargement 
and phosphoinositide production were inextricably 
linked. She showed that an auxotrophic strain starved 
for inositol developed a substantial increase in buoyant 
density in relation to wild-type or unstarved cells (Henry 
et al., 1977). Although we found that this condition does 
not block secretion, the behavior of sec l  seemed similar 
in respect to the halt in net surface growth at a restric- 
tive temperature. 
This idea set the stage for a dramatic experiment, 
which is depicted in Figure 1 of Novick et al. (1980). A 
100-fold excess of wild-type cells was mixed with sec l  
mutant cells and the mixture incubated at 37°C for 3 hr, 
followed by sedimentation on a gradient of Ludox, a 
commercial floor polish that had been adapted for the 
purpose of cell separations. Although this density gradi- 
ent material was not commercially available, we found 
a local supply at the Protex Wax Manufacturing Co., a 
business in downtown Oakland that sold Ludox in 55- 
gallon drums! Fortunately, they parted with a 5 gal. sam- 
ple, portions of which we cleaned up by passing samples 
over an activated charcoal column. Subsequently, Per- 
coil, a coated and reagent-grade form of this material, 
was produced and is now used widely in cell and organ- 
elle fractionation. In any case, Ludox gradients resulted 
in a substantial separation of the wild-type and sec l  
mutant cells, and it became clear that the gradient was 
a viable means of enriching new sec mutants. 
Through the repeated application of this approach, 
and with the skilled genetic advice of our lab technician, 
Charles Field, we collected nearly 200 mutant isolates 
that defined 23 complementation groups. Like sec l ,  all 
the mutants accumulate enzymatically active invertase 
and acid phosphatase, in most cases in a pool that is 
reversibly returned to the secretory pathway when cells 
are cooled to a permissive temperature. Most of the 
mutants affect the steady-state level of a membrane 
organelle, in particular, the endoplasmic reticulum and 
secretory vesicles. 
Some of the mutants had an anomalous effect on 
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Table 1. The Function of the Original SEC Genes 
Gene Gene Product Function Transport Stage Reference 
SEC1 SNARE binding protein 
SEC2 Exchange protein for Sec4p 
SEC3 Component of exocyst 
complex 
SEC4 Rab GTPase 
SEC5 Component of exocyst 
complex 
SEC6 Component of exocyst 
complex 
SEC7 Exchange protein for Arf 
SEC8 Component of exocyst 
complex 
SEC9 t-SNARE 
SECIO Component of exocyst 
complex 
SEC11 Component of signal 
peptidase 
SEC12 Exchange protein for Sarlp 
SECt3  Component of COP II coat 
SEC14 PI/PC transfer protein 
SECt5 Component of exocyst 
complex 
SEC16 Scaffold protein at ER exit site 
SEC17 SNARE recycling, c~-SNAP 
SEC18 SNARE recycling, NSF 
SEC19 Rab recycling, GDI 
SEC20 Component of tethering 
complex 
SEC21 Component of COP I coat 
SEC22 v-SNARE 
SEC23 Sarl GTPase activating 
protein; component of COP II 
coat 
Fusion of secretory vesicles to PM 
Delivery of secretory vesicles to PM 
Tethering of secretory vesicles to PM 
Delivery of secretory vesicles to PM 
Tethering of secretory vesicles to PM 
Tethering of secretory vesicles to PM 
Vesicle budding from Golgi 
Tethering of secretory vesicles to PM 
Fusion of secretory vesicles to PM 
Tethering of secretory vesicles to PM 
Exit of certain proteins from ER 
Vesicle budding from ER 
Vesicle budding from ER 
Vesicle budding from Golgi 
Tethering of secretory vesicles to PM 
Vesicle budding from ER 
Vesicle fusion, multiple stages 
Vesicle fusion, multiple stages 
Vesicle delivery, multiple stages 
Tethering of Golgi to ER vesicles 
Budding of Golgi to ER vesicles 
Fusion of ER to Golgi vesicles 
Vesicle budding from ER 
Carr et al., 1999 
Walch-Solimena et al., 1997 
TerBush et al., 1996 
Salminen and Novick, 1987 
TerBush et al., 1996 
TerBush et al., 1996 
Sata et al., 1998 
TerBush et al., 1996 
Brennwald et al., 1994 
TerBush et al., 1996 
B6hni et al., 1988 
Barlowe and Schekman, 1993 
Barlowe et al., 1994 
Bankaitis et al., 1990 
TerBush et al., 1996 
Espenshade t al., 1995 
Griff et al., 1992 
Wilson et al., 1989 
Garrett et al., 1994 
Lewis et al., 1997 
Hosobuchi et al., 1992 
Lian et al., 1994 
Yoshihisa et aL, 1993; Barlowe 
et al., 1994 
organelle structure. One in particular, sec7, accumulates 
a ring- or cup-shaped tubule that we called a Berkeley 
Body in honor of the odd-shaped denizens of Berkeley's 
famed Telegraph Avenue, as well as certain members 
of the faculty. Unlike most of the other sec mutants, 
sec7 cells did not discharge secretory proteins on return 
to a permissive temperature; thus, the Berkeley Body 
could not be considered an authentic intermediate in 
the secretory pathway. Fortunately, subsequent work 
showed that growth conditions influence the reversibility 
of the sec7 mutant. Incubation in low glucose allows 
cells to accumulate invertase reversibly within struc- 
tures that more closely resemble Golgi stacks (Novick 
et al., 1981). Double mutant analysis showed that this 
structure follows the ER and gives rise to mature secre- 
tory vesicles, just as had been established by more 
traditional cytologic analysis by Palade and colleagues 
in their pioneering studies on the secretory pathway in 
pancreatic exocrine cells (Palade, 1975). 
Three other organelle anomalies have also been clari- 
fied by subsequent work. sec11 mutant cells accumulate 
secretory proteins, though fairly selectively (Novick and 
Schekman, 1983), but seem not to exaggerate any or- 
ganelles. B6hni et al. (1988) showed that SEC11 encodes 
a subunit of the signal peptidase, and in its absence 
only a subset of transported proteins accumulate unpro- 
cessed within the ER. Apparently, the bulk of trans- 
ported proteins either lack a cleavable signal or are 
unimpeded in their transport by the failure to remove 
the signal peptide. 
sec 19 mutant cells accumulate a smattering of all the 
major secretory organelles, suggesting that the SEC19 
gene product acts at recurring stages along the pathway 
such that a partial defect creates multiple rate-limiting 
delays. A resolution of this curiosity came with the dis- 
covery by Salminen and Novick of one of the first of the 
rab family GTP binding proteins and their role in vesicle 
targeting (1987). In the course of their action, Sec4p and 
Ypt lp,  two members of the family that target vesicles 
at different stages in the pathway, must be retrieved 
from a target membrane in a GDP-bound form and be 
delivered to a forming vesicle where the GTP-bound 
form sustains a transport event. This recycling requires 
a GDP dissociation inhibitor (GDI), and Garrett et al. 
(1994) showed that SEC19 encodes the yeast version 
of this protein, sec19 mutants fail to recycle Sec4p and 
Yptl  p, and probably other rab proteins, causing organ- 
elles devoid of these essential targeting molecules to 
build up. 
Finally, sec17, sec18, and sec22 accumulate ER tu- 
bules as well as clusters of small vesicles, distinctly 
different in size from the mature vesicles that accumu- 
late in secl.  A refined morphologic analysis of the sec 
mutants blocked early in the pathway showed that ER- 
Golgi genes can be classified in two categories: those 
required for vesicle formation, and those required for 
vesicle targeting and fusion (Kaiser and Schekman, 
1990). SEC17 and SEC18 were shown to encode the 
yeast versions of ~-SNAP and NSF, proteins required 
for SNARE recycling (Wilson et al., 1989; Griff et al., 
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1992). SEC22 was shown to encode a SNARE protein 
required for vesicle fusion (Jiang et al., 1995). Thus, 
mutant alleles of these genes block vesicle fusion, and 
the system quickly backs up and leads to ER prolifer- 
ation. 
We now know a great deal about  each of the genes 
first identified in this paper (see Table 1). Of course, in the 
years since this report, many more genes that display a 
sec phenotype have been reported (e.g., Deshaies and 
Schekman, 1987; Newman and Ferro-Novick, 1987; 
Wuestehube et al., 1996). At this point, the level of the 
analysis has moved well beyond a descript ive phase, 
and much of the excitement focuses on mechanistic 
and atomic-level resolution of Sec protein structure and 
function. We were most fortunate to be in a position to 
begin this journey, and it has been a privi lege to witness 
the pathway revealed in its molecular detail through the 
efforts of laboratories around the world. 
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